Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07441733

Evaluate the Implementation of Using Indocyanine Green for Sentinel Lymph Node Mapping in Breast Cancer Patients

INFLUENCE II - a Pilot Study for Implementation Identification of Sentinel Lymph Nodes in Breast Cancer Patients Through Non-invasively FLUorEsceNt Imaging Using indoCyaninE Green: a Pilot Study for Implementation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Casa di Cura Dott. Pederzoli · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This single-institution pilot study uses a pre- and post-implementation design to evaluate the implementation of ICG fluorescent imaging for sentinel lymph node biopsy (SLNB) in an Italian hospital.

Detailed description

Pre-implementation: standard sentinel node procedure using 99mTc-nanocolloid, which implies 99mTc injection the day or the morning before surgery. Transition period: participating surgeons will receive on-site training, proctoring, and ongoing guidance from experienced surgeons and early adopters of the ICG method from St. Antonius Hospital, Utrecht, The Netherlands until they achieve confidence and proficiency in using ICG for SLNB. Post-implementation: 5 mg (2 ml) ICG will be injected periareolar after administration of general anesthesia and before incision. The SLN will be visualized by fluorescent imaging using a fluorescence camera. Main study endpoints: Primary endpoint is the identification rate of SLNs achieved by 99mTc-nanocolloid or the fluorescent signal of ICG. Secondary endpoints are total number of LNs removed, detection time, total operative time, complications and (serious) adverse events, loco regional recurrence after 1 year follow-up, pre-implementation expectations regarding ICG, post-implementation experiences regarding ICG including barriers and success factors.

Conditions

Interventions

TypeNameDescription
PROCEDUREICG used as a tracer for sentinel lymph nodeICG used as a tracer for sentinel lymph node instead of technetium 99
PROCEDUREtechnetium 99 used as a tracer for sentinel lymph nodetechnetium 99 used as a tracer for sentinel lymph node instead of ICG

Timeline

Start date
2024-11-07
Primary completion
2025-03-31
Completion
2026-03-01
First posted
2026-03-02
Last updated
2026-03-02

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07441733. Inclusion in this directory is not an endorsement.